Abstract
Malaria is a parasitic infestation caused by the protozoa Plasmodium, which is transmitted through the bite of the female anopheles mosquito. Pregnancy results in reduction in cell-mediated immunity. This decreased immunity makes pregnant women more susceptible to malaria than non-pregnant women. The treatment of malaria in pregnancy is determined by the stage of pregnancy at which the disease is diagnosed. In holoendemic areas, artemisin-based combination therapy (ACT) is recommended as the standard preferred treatment to improve efficacy and limit drug resistance. Intermitted preventive treatment in pregnancy is the use of anti-malarial medications at defined intervals during the pregnancy regardless of the presence or absence of confirmed malaria. It is recommended that pregnant women in holoendemic areas sleep under insecticide-treated bed-nets in order to reduce the frequency of mosquito bites during pregnancy. Effective diagnosis and treatment of malaria helps prevent the occurrence of maternal and fetal complications of malaria.
| Original language | English |
|---|---|
| Title of host publication | Protocols for High-Risk Pregnancies |
| Subtitle of host publication | An Evidence-Based Approach: Sixth Edition |
| Publisher | Wiley Blackwell |
| Pages | 232-237 |
| Number of pages | 6 |
| ISBN (Electronic) | 9781119001256 |
| ISBN (Print) | 9781119000877 |
| DOIs | |
| Publication status | Published - 1 Jan 2015 |
| Externally published | Yes |
Keywords
- Artemisin-based combination therapy
- Cell-mediated immunity
- Female anopheles mosquito
- Fetal complication
- Holoendemic areas
- Insecticide-treated bed-nets
- Intermitted preventive treatment
- Malaria
- Maternal complication
- Parasitic infestation